Patents Assigned to NESEC S.A,
  • DRUG SELECTION FOR NON-SMALL CELL LUNG CANCER THERAPY
    Publication number: 20160032403
    Abstract: The present invention provides methods for selecting a suitable anticancer drug for the treatment of patient with non-small cell lung cancer (NSCLC). The present invention also provides methods for determining drug resistance in NSCLC patients receiving EGFR inhibitor therapy.
    Type: Application
    Filed: July 29, 2015
    Publication date: February 4, 2016
    Applicant: NESEC S.A,
    Inventors: Sharat Singh, Phillip Kim, Steven Lockton